Currently, the scientific data on liraglutide dosing stems from clinical trials of Victoza and Saxenda, which have studied the peptide regarding its effects on conditions such as diabetes and obesity
Asbaghi O, Ghanbari N, Shekari M, et al
Notably, this was achieved in a shorter timeframe than the tirzepatide results, and with the weight loss curve still trending downward at the study endpoint suggesting the maximum effect had not yet been reached
Your body gets the message that youre full clearly and quickly
In 1999, orlistat became the first drug approved for chronic weight management, acting by reducing intestinal fat absorption [9]
It is discussed in some online communities, but there is very limited scientific evidence supporting its safety or effectiveness